LEXINGTON, Mass., June 16, 2020 /PRNewswire/ -- Agenus Inc.
(NASDAQ: AGEN), an immuno-oncology company with an extensive
pipeline of agents designed to activate immune response to cancers
and infectious diseases, announces that it will host its 2020
Annual Shareholders Meeting virtually due to public health concerns
related to the COVID-19.
The annual meeting will begin at 5:00pm
ET on June 16, 2020 and will
be conducted in a virtual format only. Registration for
attendees will start at 4:30 p.m. ET
To participate in the virtual Annual Shareholders Meeting,
shareholders should visit
www.virtualshareholdermeeting.com/AGEN2020 and enter the 16-digit
control number found in their proxy materials. Guests may also
access the virtual Annual Shareholders Meeting but in listen-only
mode. No control number is required for guests.
Webcast Information:
Date: Tuesday, June 16, 2020
Time: 5:00 p.m. ET
Live Webcast: accessible from the Company's website
at https://investor.agenusbio.com/presentation-webcasts or
with this link www.virtualshareholdermeeting.com/AGEN2020
A replay will be available on the Company's website after the
call and will remain available for one year.
About Agenus
Agenus is a clinical-stage immuno-oncology company focused on
the discovery and development of therapies that engage the body's
immune system to fight cancer and infections. The Company's vision
is to expand the patient populations benefiting from cancer
immunotherapy by pursuing combination approaches that leverage a
broad repertoire of antibody therapeutics, adoptive cell therapies
(through its AgenTus Therapeutics subsidiary), and proprietary
cancer vaccine platforms. The Company is equipped with a suite of
antibody discovery platforms and a state-of-the-art GMP
manufacturing facility with the capacity to support clinical
programs. Agenus is headquartered in Lexington, MA. For more information, please
visit www.agenusbio.com and our Twitter handle @agenus_bio.
Information that may be important to investors will be routinely
posted on our website and twitter.
Contact:
Agenus Inc.
Jennifer
Buell, PhD
781-674-4420
Jennifer.Buell@agenusbio.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/agenus-announces-virtual-annual-shareholders-meeting-301077706.html
SOURCE Agenus Inc.